Sat.Aug 28, 2021 - Fri.Sep 03, 2021

article thumbnail

Italian ‘chatbot’ predicted COVID-19 spikes, says study

pharmaphorum

An online tool used by people in Italy to manage their potential exposure to COVID-19 using a simple chat interface has shown that it can spot emerging trends days ahead of the national surveillance system. The decision support system (DSS) – developed by Italian digital health startup Paginemediche – provided a way for people to assess and interpret their symptoms and provide guidance on what to do next, such as self-isolate or seek out a test.

Hospitals 145
article thumbnail

Hospitals stopped suing patients for unpaid medical debt after media exposure, public pressure, study suggests

Fierce Healthcare

Hospitals stopped suing patients for unpaid medical debt after media exposure, public pressure, study suggests. dmuoio. Tue, 08/31/2021 - 17:13.

Hospitals 138
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Revive Therapeutics reports progress with Phase III COVID-19 trial

Outsourcing Pharma

A leader from the rare and infectious disease treatment specialist talks about ongoing research into a potential treatment for mild-to-moderate COVID-19.

131
131
article thumbnail

The Best Ointment for Burns: OTC vs. Rx

BuzzRx

Burns can result from heat, excessive sun exposure, radiation exposure, or contact with chemicals or electricity. Depending on the severity and location, they can range from a minor problem treated at home to a life-threatening emergency requiring medical treatment in a hospital. More widespread and deeper burns may require specialized care at a burn care center.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Funding round swells digital health firm Whoop’s value to $3.6bn

pharmaphorum

Fitness wearable company Whoop has raised another $200 million in funding that will help fund its expansion into international markets – and take on deep-pocketed rivals like Amazon, Apple and Google. The sixth-round financing was led by SoftBank’s Vision Fund 2, taking the total raised by the company to date to around $400 million, and catapults Whoop’s valuation to a massive $3.6 billion.

137
137
article thumbnail

Apple plans to add blood pressure monitoring, thermometer to smartwatch: report

Fierce Healthcare

Apple plans to add blood pressure monitoring, thermometer to smartwatch: report. hlandi. Wed, 09/01/2021 - 13:52.

145
145

More Trending

article thumbnail

Top 4 Market Disruptors Affecting Every Company in the Energy Sector

Fuld

Over 80% of the country’s energy infrastructure is owned by the private sector. Here’s a condensed look at the energy industry and intelligence to put you ahead. 1. A Crossroads For Combustion vs. Electric Technology. The energy industry is finally waking up to reality. Sooner or later, the global economy needs to transition from fossil fuels to more sustainable and lower-carbon energy sources.

52
article thumbnail

Real-world study suggest AI may improve atrial fibrillation screening

pharmaphorum

An artificial intelligence algorithm already shown to be able to detect atrial fibrillation (AF) in clinical testing has also shown its worth in a real-world setting, according to its developers. The AI – developed by the Bristol Myers Squibb-Pfizer Alliance on cardiovascular disease – was developed using machine learning from a UK dataset of almost 3 million patients and previously found to be more effective than existing testing at identifying patients at risk of AF based on retrospective stud

128
128
article thumbnail

AppliedVR taps Curebase to run at-home clinical trials testing VR for pain treatment

Fierce Healthcare

AppliedVR taps Curebase to run at-home clinical trials testing VR for pain treatment. hlandi. Sun, 08/29/2021 - 20:50.

141
141
article thumbnail

Curebase to partner on VR-based chronic pain clinical trials

Outsourcing Pharma

The decentralized trial tech firm will work with Applied VR on five studies testing the viability of virtual-reality therapy in treating pain patients.

105
105
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

DoKaSch Temperature Solutions opens new service station in India

Pharma Mirror

Frankfurt/Hyderabad, DoKaSch Temperature Solutions has opened a new service station in India. It is located at GMR Hyderabad Air Cargo terminal. Strategically, the Hyderabad Airport location is a very important network station for the global supply of lifesaving medicines given Hyderabad’s status as a major pharma production and export hub. With the new location in India, DoKaSch strengthens its network in the region and globally.

52
article thumbnail

Purdue bankruptcy court hands immunity to Sackler family

pharmaphorum

A US federal judge has approved a bankruptcy settlement for Purdue Pharma that grants the Sackler family that owned the business immunity from any further civil lawsuits accusing them of contributing to opioid epidemic – to the consternation of campaigners. The agreement will dissolve the OxyContin (oxycodone) manufacturer – which Judge Robert Drain said was a “bitter result” – will see around $4.5 billion being paid out by the Sackler family to projects that support victims of the o

article thumbnail

Federal judge grants final approval of $575M settlement against Sutter Health

Fierce Healthcare

Federal judge grants final approval of $575M settlement against Sutter Health. rking. Mon, 08/30/2021 - 13:13.

145
145
article thumbnail

UK consortium lands grant to construct digital supply chain

Outsourcing Pharma

FarmaTrust is helping assemble a collective of public and private firms working on solutions for smart manufacturing and creating medicines of the future.

105
105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

How to Improve Metabolic Health

BuzzRx

How often have you heard a skinny person say, “I have a really good metabolism”? If you struggle to maintain a healthy body weight , this phrase can be frustrating and annoying. But metabolism is much more than burning off calories and fats that you consume. Your metabolic health affects every part of your body. And good metabolic health is all about balance.

article thumbnail

How pharma can help the post-COVID recovery of European cancer care

pharmaphorum

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians implemented during the acute phase of the pandemic, with a focus on the way in which treatment strategies were altered. The publication, which has been supported by Accord Healthcare, also provides a series of recommendations for how the pharmaceutical industry can continue to support cancer care for the next 12 months and looks at what physicians want

article thumbnail

Medicare trustees project hospital fund to run out in 2026, same deadline as year before

Fierce Healthcare

Medicare trustees project hospital fund to run out in 2026, same deadline as year before. rking. Tue, 08/31/2021 - 17:02.

Hospitals 136
article thumbnail

Johnson & Johnson pulls HIV vaccine trial in Africa; but pledges to continue with Phase 3 Mosaico study

Outsourcing Pharma

Johnson & Johnson has announced results from the primary analysis of its Imbokodo Phase 2b HIV vaccine clinical trial, with data showing the investigational HIV vaccine candidate did not provide sufficient protection against HIV infection. A Phase 3 trial with a different composition of the vaccine regimen and different populations, however, will continue.

article thumbnail

Sharing evidence with NICE is part of a broader approach to help Cochrane to identify priority reviews

NICE

This week, Cochrane and NICE signed a collaborative agreement which creates a formal process for people who are preparing reviews for the Cochrane Library to share their findings with NICE. Cochrane are no strangers to working with NICE, and over the last few years Cochrane Review Groups have been approached by NICE guideline committees to support the guideline process.

52
article thumbnail

FDA clears J&J’s twice-yearly Invega for schizophrenia

pharmaphorum

One of the biggest challenges to treating schizophrenia is non-compliance with treatment, but Johnson & Johnson’s pharma unit Janssen is trumpeting a new version of its Invega drug that could solve that problem. The FDA has just approved Janssen’s Invega Hafyera (paliperidone), a twice-yearly injectable formulation that extends the company’s big-selling brand and offers the fewest doses per year of any schizophrenia medicine.

FDA 109
article thumbnail

Medicare's hospital fund is running out of money. Experts have 5 ideas on how to help

Fierce Healthcare

Medicare's hospital fund is running out of money. Experts have 5 ideas on how to help. rking. Wed, 09/01/2021 - 15:50.

Hospitals 137
article thumbnail

Survey: cancer patients missing out on much-needed genetic testing

Outsourcing Pharma

According to patient-matching specialist TrialJectory, 90% of cancer patients know the vitality of genetic testing but more than half are not being tested.

80
article thumbnail

Lumiio streamlines data collection, changing the face of global health collaboration

Pharma Mirror

CALGARY, AB: Reliable, consistent, and applicable data is a key feature of well-executed research and the development of new treatments. For some diseases and disorders, possible study participants are spread out across the world, preventing effective research and slowing down the process of improving quality of life for the people who need them most.Lumiio is determined to change this.

52
article thumbnail

NICE backs NHS use of Novartis’ cholesterol drug Leqvio

pharmaphorum

Novartis’ cholesterol-lowering drug Leqvio will be made available on the NHS in England and Wales, and could help to prevent up to 30,000 deaths, according to NICE. The PCSK9-targeting oligonucleotide – which is already available in Scotland – requires dosing just twice a year and has been approved by the health technology assessment (HTA) agency for use in people with atherosclerotic cardiovascular disease (ASCVD) who can’t reach target cholesterol levels with oral statins alone.

98
article thumbnail

CDC: 'Perfect storm' fueled a spike in healthcare-associated infections in 2020

Fierce Healthcare

CDC: 'Perfect storm' fueled a spike in healthcare-associated infections in 2020. dmuoio. Thu, 09/02/2021 - 14:50.

135
135
article thumbnail

Study: Cancer patients frustrated with slow rate of treatment innovations

Outsourcing Pharma

Cota has released a survey revealing about two-thirds of cancer patients and their families are unsatisfied at the speed of cancer treatment development.

70
article thumbnail

Interview #6: Deprescribing experiences from a nurse in long-term care and palliative care

The deprescribing.org Blog

Hello deprescribers! Today we have an interview with Ana Amaral, a nurse and researcher from Portugal. We asked her about her experience as a nurse working in long-term care and palliative care and about her Master’s work related to the role of nurses in deprescribing in this setting. Here we go! Q: You recently submitted your thesis about d eprescribing in long-term care and palliative care.

article thumbnail

FDA schedules adcomm for Pfizer’s COVID booster filing

pharmaphorum

The FDA will hold an advisory committee meeting later this month to discuss Pfizer and BioNTech’s filing for approval of a third booster dose of their COVID-19 vaccine Comirnaty in people aged 16 and over. The adcomm is scheduled for 17 September and will consider the Pfizer/BioNTech filing as well as booster doses more generally. The news comes as Moderna has just announced the submission of initial data to the FDA for its own COVID-19 vaccine booster.

FDA 90
article thumbnail

FBI warns healthcare systems of Hive ransomware following Memorial Health System attack

Fierce Healthcare

FBI warns healthcare systems of Hive ransomware following Memorial Health System attack. elucas. Wed, 09/01/2021 - 11:54.

131
131
article thumbnail

Azelis publishes its 2020 sustainability report

Pharma Mirror

SINGAPORE- Azelis, a leading innovative service provider in the specialty chemicals and food ingredients industry, is proud to publish its second sustainability report which covers the 2020 group-wide sustainability performance. Highlights & rationale– The report showcases Azelis’ environmental, social, and governance (ESG) commitments and reinforces its ambitions to become the world-leading provider of sustainable solutions and services– Azelis sustainability strategy, Act

52
article thumbnail

People on the Move: September 2021

Outsourcing Pharma

This monthâs news on new hires, board launches, acquisitions, and other important news includes items on Pfizer, Javara, Clinical Ink, and other companies.

52
article thumbnail

More trouble for Astellas as AT132 gene therapy trial is halted again

pharmaphorum

Astellas has halted dosing in a study of its AT132 gene therapy for the rare disease X-linked myotubular myopathy (XLMTM) for the second time after another serious adverse event (SAE) linked to possible liver damage. The ASPIRO trial of AT132 has been paused after abnormal liver function tests (LFTs) were seen in a patient receiving the gene therapy, and information on the adverse event has been shared with regulators, according to the drugmaker.

FDA 80
article thumbnail

MedPAC considers one-time funding boosts for Medicare in 2023 due to COVID-19 confusion

Fierce Healthcare

MedPAC considers one-time funding boosts for Medicare in 2023 due to COVID-19 confusion. rking. Thu, 09/02/2021 - 17:11.

131
131
article thumbnail

Agilex Biolabs Partners with Endpoints News for Webinar on Rapid Vaccine Development in Australia

Pharma Mirror

ADELAIDE- Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif. Agilex Biolabs’ Director, Immunoassay, Kurt J.